Abstract
Pheochromocytoma contains and may synthesize a large number of peptides such as opioids (Leu-, Met-enkephalin), VIP, gastrin, calcitonin gene related peptide (CGRP), somatostatin, and adrenocorticotrophic hormone (ACTH). Also, circulating level of these peptides may be elevated. Although the precise contribution of these peptides secretion to the clinical features are largely unknown, it can be suggested that specific endocrine system could be involved in ectopic hormone production by pheochromocytoma. Indeed, it has occasionally been reported that pheochromocytoma is associated with Cushings syndrome resulting from excess ACTH production. As there are already many excellent reviews of this area, the discussion that follows will mainly focus on our data, including 1.Opioids, 2.Adrenomedullin (AM) and proadrenomedullin N-terminal 20 peptide (PAMP), 3.Natriuretic peptides (NPs), 4.Leptin, 5.Endothelin 6. Angiotensin II receptor, 8. Chromogranin A and Catestatin.
Keywords: pheochromocytoma, calcitonin gene related peptide, somatostatin, adrenocorticotrophic, adrenomedullin
Current Pharmacogenomics
Title: Peptidergic Regulation of Pheochromocytoma
Volume: 1 Issue: 2
Author(s): Kazuhiro Takekoshi, Kazumasa Isobe, Yasushi Kawakami, Shunsuke Shibuya, Toshiaki Nakai and Yukichi Okuda
Affiliation:
Keywords: pheochromocytoma, calcitonin gene related peptide, somatostatin, adrenocorticotrophic, adrenomedullin
Abstract: Pheochromocytoma contains and may synthesize a large number of peptides such as opioids (Leu-, Met-enkephalin), VIP, gastrin, calcitonin gene related peptide (CGRP), somatostatin, and adrenocorticotrophic hormone (ACTH). Also, circulating level of these peptides may be elevated. Although the precise contribution of these peptides secretion to the clinical features are largely unknown, it can be suggested that specific endocrine system could be involved in ectopic hormone production by pheochromocytoma. Indeed, it has occasionally been reported that pheochromocytoma is associated with Cushings syndrome resulting from excess ACTH production. As there are already many excellent reviews of this area, the discussion that follows will mainly focus on our data, including 1.Opioids, 2.Adrenomedullin (AM) and proadrenomedullin N-terminal 20 peptide (PAMP), 3.Natriuretic peptides (NPs), 4.Leptin, 5.Endothelin 6. Angiotensin II receptor, 8. Chromogranin A and Catestatin.
Export Options
About this article
Cite this article as:
Takekoshi Kazuhiro, Isobe Kazumasa, Kawakami Yasushi, Shibuya Shunsuke, Nakai Toshiaki and Okuda Yukichi, Peptidergic Regulation of Pheochromocytoma, Current Pharmacogenomics 2003; 1(2) . https://dx.doi.org/10.2174/1570160033476331
DOI https://dx.doi.org/10.2174/1570160033476331 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Clinical and Molecular Perspectives of Monogenic Hypertension
Current Hypertension Reviews “Vascular Incontinence” and Normal-Pressure Hydrocephalus: Two Commonsources of Elderly Incontinence with Brain Etiologies
Current Drug Therapy Long-Term Multimodal Therapy (Verapamil Associated with Propolis, Blueberry, Vitamin E and Local Diclofenac) on Patients with Peyronie's Disease (Chronic Inflammation of the Tunica Albuginea). Results of a Controlled Study
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacological Evidence of α -adrenergic Receptors in the Hypotensive Effect of Chamaemulum nobile L.
Cardiovascular & Hematological Agents in Medicinal Chemistry Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Reviews on Recent Clinical Trials Type 2 Diabetes Mellitus and Invokana: An FDA Approved Drug
Current Diabetes Reviews Aortic Stenosis, Aortic Regurgitation and Arterial Hypertension
Current Vascular Pharmacology Perspectives on Therapeutic Target for Multiple System Atrophy
Recent Patents on Regenerative Medicine Anesthetic Neuroprotection: Antecedents and An Appraisal of Preclinical and Clinical Data Quality
Current Pharmaceutical Design Exploring New CGRP Family Peptides and their Receptors in Vertebrates
Current Protein & Peptide Science Anti-Ophidian Properties of Herbal Medicinal Plants: Could it be a Remedy for Snake Bite Envenomation?
Current Drug Discovery Technologies Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Concise Review of the Rationale for Pulmonary Embolism Treatment and Endovascular Device Therapies
Current Cardiology Reviews Medicinal Properties of the Jamaican Pepper Plant Pimenta dioica and Allspice
Current Drug Targets Advanced Therapies For End-Stage Heart Failure
Current Cardiology Reviews Post-stroke Movement Disorders: Clinical Manifestations and Pharmacological Management
Current Neuropharmacology Adipose Tissue and Bone Marrow as Sources for Cell-based Therapeutic Angiogenesis in Ischemic Tissues: Biological Foundation and Clinical Prospects for Age-related Vascular Disease
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Aldosterone to Renin Ratio (ARR) in Clinical use, with Reference to the Primary Care Setting: ARR to Whom, When, How, What for?
Current Hypertension Reviews Chiral Kinase Inhibitors
Current Topics in Medicinal Chemistry